Cross-border Real Estate Developers | 'Escape' | Medical Industry
Pharma News March 20th The real estate golden age has declined, the health industry has gradually warmed up, and real estate companies have straddled the medical health industry.
Wanda, Evergrande, Vanke, R&F, and Ocean... Large and small real estate companies are rushing to eat the big health industry cake.
In this process of cross-border transformation, how is the medical device industry divided?
2 years after cross-border, Yihua Health sells medical equipment
Among A-share listed companies, Yihua Health is a dissimilarity.
This company from Guangdong, formerly known as Yihua Real Estate Co., Ltd., had a “disabled warrior” since 2014, completely stripped the real estate business, and fully transformed into a medical and health industry.
The company changed its name to 'Yihua Health Medical Co., Ltd.', another way to buy and buy, and won several subsidiaries and online hospitals. In last year alone, Yihua Health had more than a dozen transactions in the health field. .
In the way of Yihua health cross-border to medical and health industry, Aoole Medical Devices (Shenzhen) Co., Ltd. was an important step.
In 2015, Yihua Health announced that it had bought 100% equity of Ioole for $300 million, and the transaction was completed in early 2016. Iorole is a manufacturer of medical devices. Its main products are blood pressure monitors, blood glucose meters, and thermometers. Yihua Health once stated that the acquisition of Ao Le was beneficial to the company's entry into medical equipment and improved its strategic layout in the medical and health industry.
However, just over two years later, Yihua Health sold it again.
In December 2017, Yihua Health announced that it will transfer 100% equity of Ailele to Wuhu Jiujiu Equity Investment Partnership (Limited Partnership) for 300 million yuan. The actual controller of Wuhu 9th is Xiao Shicheng, who was also Aoole sells to Yihua healthy people.
After a round of circling, Ioly returned to the original owner's hands. The last person to enjoy this purchase was the well-known condom brand company Jasper. After being sold abroad for 11 years, he returned to life. medicine In the hands of others, however, it was a high premium for Renfubang to buy back Jasper, and it was 'original price' for Xiao Shicheng to buy back Ao Leqi.
Strategic transformation? Performance does not meet expectations?
This peculiar deal triggered the attention of the Shenzhen Stock Exchange. Yihua Health Response: The company is to further focus on strategy and actively expand business plans for medical industry services and pension industry services. Another Yihua health executive told reporters that the company's main business Business will not have medical instruments This is a piece.
After more than two years of cross-border development in the medical device industry, Yihua Health, which was transformed from a real estate firm, decided to leave the medical device industry.
And then carefully investigate the performance of Ioole in recent years.
Prior to the sale, Ioole's operating revenue in 2013 and 2014 were both over 47 million yuan, and the net loss was several hundred thousand yuan. In January-July 2015, the revenue was over 47.4 million yuan, and the net profit was nearly 1.5 million yuan.
Yihua Health has a performance commitment when it buys Aolol. From 2016 to 2020, Aolor needs to achieve a net profit of not less than 20 million yuan, 35.02 million yuan, 45 million yuan, 50 million yuan and 55.01 million yuan, respectively. yuan.
After the actual sale, Ioole achieved a net profit of 29.1173 million yuan in 2015, a net profit of 20.2374 million yuan in 2016, and a net profit of 3.5556 million yuan in January-September 2017 (64.480 million yuan in revenue).
As can be seen from the data, Ioole completed its 2016 performance commitment, but only completed 10% of the performance commitment in the first three quarters of 2017.
On the surface, Iowa Health sells Ioor to strategically focus on pensions and the medical industry, but also because cross-border to medical device industry is unsuccessful and performance is not as expected.
After more than two years in the cross-border medical device industry, Yihua Health decided to 'escape' from the medical and medical industry. At least on the face of it, more inside information is not known.
After leaving the border, other real estate developers have done it.
There is a precedent for real estate developers to cross the border to the medical device industry. Yihua Health is not the first one.
Back in 2012, listed on the Shenzhen Stock Exchange enterprise Wanfang Real Estate (now known as 'Wanfang Development') purchased 100% equity of Beijing Boren Yongtai Medical Devices Co., Ltd. for RMB 28 million in the context of a net loss in real estate business. This is a medical equipment company.
Then, in 2014, which was also less than two years later, Wanfang Development announced that it will sell 100% equity of Boren Yongtai for 30 million yuan. The reasons for the sale are: After the merger and acquisition, the operating conditions of Boren Yongtai have not been overdue. In 2013, the net profit loss was more than 300,000 yuan. To ensure the company's operating results, it reduced losses and sold it.
Then, once the development of Wanfang, which once crossed the boundaries of the medical device industry, is actually no longer involved in the medical device industry. However, the development of one foot continues into the medical and health industry, and its loyalty to health is not changed. .
The company's 'Changing cages for birds' all the way, the timber business part of the original real estate business has basically been put in place, and it has also bought a lot of medical informatization and Internet pharmaceutical assets in succession. For example, the equity and capital increase of Chengdu Yi-Fang Medical. , funding establishment hospital Management company, acquisition of ICT Netease and so on.
Wanfang develops it to medical care health The transformation of the field focuses on the 'Internet+Medical' hot sector.
Real estate developers do not love the medical industry but they are still affecting the industry.
In recent years, the golden age of real estate has gradually declined, and the health industry has gradually warmed up. Real estate companies have crossed the boundaries of medical and health industries.
Wanda, Evergrande, Vanke, R&F, and Ocean... Large and small real estate companies are rushing to eat the big health industry cake.
In this cross-border transformation process, online and offline medical care is highly sought after.
For example, Wanda Investment International Hospital, Dental Clinic, China Vanke Children's Hospital, R & F International Hospital, Ocean Clinic, Greenview Specialty Hospital, Jiahe International Hospital, Evergrande Plastic Surgery Hospital, Oncology Hospital, Internet Community Hospital and so on.
For another example, the above mentioned Yihua healthy network hospital, the development of Internet medical care, etc.
Real estate developers have come with huge sums of money. The medical device industry has actually not been able to be directly assigned to embarrassment. The rare cross-border behavior has also quickly stopped.
From mountain to mountain, the medical device industry is not easy to cross-border because of its complexity and particularity. As in the warp knitting industry, HTC, cross-border medical devices have been 'repeated', but they have persisted for many years until they turn around. 3. It's rare after all that it can be expanded again.
The profit-making real estate developers are attracted by the medical device industry. Of course, although real estate developers do not love the medical device industry, they will benefit from the expansion of their cross-border market to the medical and health industry. .
Under the catalysis of huge amounts of money, private medical institutions are becoming more important terminals for the sale of medical devices. The market is changing, and companies in the industry must also change!